DE69920959D1 - Verwendung von riluzol zur behandlung von akustischen traumazuständen - Google Patents

Verwendung von riluzol zur behandlung von akustischen traumazuständen

Info

Publication number
DE69920959D1
DE69920959D1 DE69920959T DE69920959T DE69920959D1 DE 69920959 D1 DE69920959 D1 DE 69920959D1 DE 69920959 T DE69920959 T DE 69920959T DE 69920959 T DE69920959 T DE 69920959T DE 69920959 D1 DE69920959 D1 DE 69920959D1
Authority
DE
Germany
Prior art keywords
riluzol
treating acoustic
dream
conditions
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920959T
Other languages
English (en)
Other versions
DE69920959T2 (de
Inventor
Jean-Marie Stutzmann
John Randle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69920959D1 publication Critical patent/DE69920959D1/de
Publication of DE69920959T2 publication Critical patent/DE69920959T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DE69920959T 1998-12-15 1999-12-13 Verwendung von riluzol zur behandlung von akustischen traumazuständen Expired - Lifetime DE69920959T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9815834A FR2787028B1 (fr) 1998-12-15 1998-12-15 Utilisation du riluzole dans le traitement des traumatismes acoustiques
FR9815834 1998-12-15
PCT/FR1999/003108 WO2000035447A1 (fr) 1998-12-15 1999-12-13 Utilisation du riluzole dans le traitement des traumatismes acoustiques

Publications (2)

Publication Number Publication Date
DE69920959D1 true DE69920959D1 (de) 2004-11-11
DE69920959T2 DE69920959T2 (de) 2005-09-01

Family

ID=9533998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920959T Expired - Lifetime DE69920959T2 (de) 1998-12-15 1999-12-13 Verwendung von riluzol zur behandlung von akustischen traumazuständen

Country Status (20)

Country Link
US (1) US6660757B2 (de)
EP (1) EP1140080B1 (de)
JP (2) JP4831866B2 (de)
KR (1) KR100641473B1 (de)
AT (1) ATE278401T1 (de)
AU (1) AU773639B2 (de)
BR (1) BR9916244A (de)
CA (1) CA2355359C (de)
CZ (1) CZ292078B6 (de)
DE (1) DE69920959T2 (de)
ES (1) ES2229796T3 (de)
FR (1) FR2787028B1 (de)
HU (1) HU228889B1 (de)
IL (2) IL143280A0 (de)
NO (1) NO326764B1 (de)
PT (1) PT1140080E (de)
SK (1) SK285206B6 (de)
UA (1) UA72229C2 (de)
WO (1) WO2000035447A1 (de)
ZA (1) ZA200104827B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
EP2076174A4 (de) * 2006-10-13 2012-10-24 Univ North Carolina Gerät und verfahren zur akustischen oder mechanischen stimulation einer cochlea und intracochleare aufzeichnung von mechanisch oder akustisch evozierten hörpotentialen in der cochlea
TW201039383A (en) * 2009-04-17 2010-11-01 Arima Optoelectronics Corp Semiconductor chip electrode structure and manufacturing method thereof
EP3616686B8 (de) 2014-11-21 2021-06-23 Biohaven Pharmaceutical Holding Company Ltd. Sublinguale formulierung von riluzol
EP3220890A1 (de) * 2014-11-21 2017-09-27 Biohaven Pharmaceutical Holding Company Ltd. Sublinguale verabreichung von riluzol
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en) 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FR2619713B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2619712B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700116B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants comme radioprotecteurs.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
PT784973E (pt) * 1995-10-10 2002-06-28 Pfizer Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques

Also Published As

Publication number Publication date
ES2229796T3 (es) 2005-04-16
DE69920959T2 (de) 2005-09-01
IL143280A0 (en) 2002-04-21
KR100641473B1 (ko) 2006-10-31
EP1140080A1 (de) 2001-10-10
ZA200104827B (en) 2002-09-13
FR2787028A1 (fr) 2000-06-16
US20020004516A1 (en) 2002-01-10
JP4831866B2 (ja) 2011-12-07
NO326764B1 (no) 2009-02-09
BR9916244A (pt) 2001-10-02
UA72229C2 (en) 2005-02-15
NO20012777L (no) 2001-06-06
HU228889B1 (en) 2013-06-28
CA2355359C (fr) 2009-02-03
HUP0104698A3 (en) 2004-05-28
AU773639B2 (en) 2004-05-27
EP1140080B1 (de) 2004-10-06
JP2002532424A (ja) 2002-10-02
PT1140080E (pt) 2005-01-31
KR20010101192A (ko) 2001-11-14
SK8242001A3 (en) 2001-12-03
JP2011219497A (ja) 2011-11-04
US6660757B2 (en) 2003-12-09
CZ292078B6 (cs) 2003-07-16
HUP0104698A2 (hu) 2002-04-29
NO20012777D0 (no) 2001-06-06
AU1569600A (en) 2000-07-03
SK285206B6 (sk) 2006-08-03
CA2355359A1 (fr) 2000-06-22
FR2787028B1 (fr) 2002-10-18
ATE278401T1 (de) 2004-10-15
IL143280A (en) 2007-10-31
JP5536722B2 (ja) 2014-07-02
WO2000035447A1 (fr) 2000-06-22
CZ20012085A3 (cs) 2001-09-12

Similar Documents

Publication Publication Date Title
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
ATE357272T1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
ATE204164T1 (de) Pflaster zur behandlung von nagelmykosen
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE313328T1 (de) Verfahren zur behandlung von mittelohrinfektionen
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
DE69920959D1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen
ATE234617T1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE59914312D1 (de) Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien
WO2000027376A3 (de) Verwendung von thiolverbindungen, oxidoreduktasen und/oder hydrolasen zur behandlung des tinnitus, insbesondere des chronischen tinnitus
ATE258064T1 (de) Verwendung von antileukoprotease zur behandlung von endometriose
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC